InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
-0.02%
)
US TECH 100
17,714.80
(
0.18%
)
Dow Jones
39,431.51
(
-0.21%
)
Brent Oil
83.21
(
1.00%
)
Bitcoin
63,082.98
(
2.66%
)
Post# of 672
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

WeeZuhl

Send PM Follow Ignore
Followers 53
Posts 1775
Boards Moderated 0
Alias Born 03/22/2015

WeeZuhl

Re: None

Friday, 01/13/2017 9:14:04 PM

Friday, January 13, 2017 9:14:04 PM

Post# of 672
FDA confirms Egalet's story.


http://www.medpagetoday.com/neurology/generalneurology/62441


An FDA spokesperson told MedPage Today that MorphaBond, another morphine product, has "marketing exclusivity for labeling describing the expected reduction of abuse of single-entity, extended-release morphine by the intranasal route due to physicochemical properties."


Historic note: Until his life's destiny was further clarified, Robin Hood spent several years robbing from the rich and giving to the porcupines. (G. Larson 7/26/82)

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up